Michael R MacDonald
Overview
Explore the profile of Michael R MacDonald including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chow W, Aung C, Tong S, Goh G, Lee S, MacDonald M, et al.
J Telemed Telecare
. 2019 Feb;
26(6):332-340.
PMID: 30782070
Aims: Our study aimed to compare the effectiveness of telemonitoring over structured telephone support in reducing heart failure-related healthcare utilization. Methods: This was a non-randomised controlled study comparing 150 recently...
12.
Tromp J, MacDonald M, Tay W, Teng T, Hung C, Narasimhan C, et al.
Circulation
. 2018 Dec;
138(24):2763-2773.
PMID: 30565987
Background: Heart failure with preserved ejection fraction (HFpEF), traditionally considered a disease of the elderly, may also affect younger patients. However, little is known about HFpEF in the young. Methods:...
13.
Go Y, Sellmair R, Allen Jr J, Sahlen A, Bulluck H, Sim D, et al.
Eur J Heart Fail
. 2018 Dec;
21(3):311-318.
PMID: 30549171
Aims: We aimed to identify a 'frequent admitter' phenotype among patients admitted for acute decompensated heart failure (HF). Methods And Results: We studied 10 363 patients in a population-based prospective...
14.
Chandramouli C, Teng T, Tay W, Yap J, MacDonald M, Tromp J, et al.
Eur J Heart Fail
. 2018 Dec;
21(3):297-307.
PMID: 30548089
Aims: To examine sex differences in clinical characteristics, echocardiographic features, quality of life and 1-year death or heart failure (HF) hospitalization outcomes in patients with/without diabetes mellitus (DM). Methods And...
15.
Teng T, Tromp J, Tay W, Anand I, Ouwerkerk W, Chopra V, et al.
Lancet Glob Health
. 2018 Aug;
6(9):e1008-e1018.
PMID: 30103979
Background: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), β blockers, and mineralocorticoid receptor antagonists (MRAs) are of proven benefit and are recommended by guidelines for management of...
16.
Tromp J, Tay W, Ouwerkerk W, Teng T, Yap J, MacDonald M, et al.
PLoS Med
. 2018 May;
15(5):e1002583.
PMID: 29799848
[This corrects the article DOI: 10.1371/journal.pmed.1002541.].
17.
Tromp J, Tay W, Ouwerkerk W, Teng T, Yap J, MacDonald M, et al.
PLoS Med
. 2018 Mar;
15(3):e1002541.
PMID: 29584721
Background: Comorbidities are common in patients with heart failure (HF) and complicate treatment and outcomes. We identified patterns of multimorbidity in Asian patients with HF and their association with patients'...
18.
Chia Y, Teng T, Tan E, Tay W, Richards A, Chin C, et al.
Circ Cardiovasc Qual Outcomes
. 2017 Nov;
10(11).
PMID: 29150533
Background: Implantable cardioverter defibrillators (ICDs) are lifesaving devices for patients with heart failure (HF) and reduced ejection fraction. However, utilization and determinants of ICD insertion in Asia are poorly defined....
19.
Wong C, Hawkins N, Ezekowitz J, Jhund P, Savu A, MacDonald M, et al.
Can J Cardiol
. 2017 Sep;
33(11):1472-1477.
PMID: 28941947
Background: Data on young patients with heart failure (HF) are sparse. We examined the characteristics, health care use, and survival of younger vs older patients with HF. Methods: We performed...
20.
Huang W, Chai S, Lee S, MacDonald M, Gerard Leong K
Am J Cardiol
. 2017 May;
119(12):2017-2020.
PMID: 28477861
Heart failure with preserved ejection fraction (HFpEF) has a high clinical burden and constitutes approximately 20% to 30% of patients with heart failure in Asia. Impaired global longitudinal strain (GLS),...